ST-001 nanoFenretinide

fenretinide · SciTech Development, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ST-001 nanoFenretinide, covering 2025-09-22 to 2025-12-15. Get the full timeline:

Most recent: Clinical Trial Update: ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer [Phase 1]